4.7 Review

Targeting xenobiotic receptors PXR and CAR in human diseases

Journal

DRUG DISCOVERY TODAY
Volume 20, Issue 5, Pages 618-628

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2014.11.011

Keywords

-

Funding

  1. American Lebanese Syrian Associated Charities (ALSAC)
  2. UNCF/Merck Postdoctoral Science Research Fellowship
  3. St Jude Children's Research Hospital
  4. National Institutes of Health [GM086415, GM110034, P30-CA21765]

Ask authors/readers for more resources

Nuclear receptors such as the pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are xenobiotic receptors regulating not only drug metabolism and disposition but also various human diseases such as cancer, diabetes, inflammatory disease, metabolic disease and liver diseases, suggesting that PXR and CAR are promising targets for drug discovery. Consequently, there is an urgent need to discover and develop small molecules that target these PXR- and/or CAR-mediated human-disease-related pathways for relevant therapeutic applications. This review proposes approaches to target PXR and CAR, either individually or simultaneously, in the context of various human diseases, taking into consideration the structural differences between PXR and CAR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available